Research ArticleResearch Letter
Communication of Drug Efficacy Information via a Popular Online Platform
Jonathan J. Darrow and Elizaveta Borisova
The Journal of the American Board of Family
Medicine July 2022, 35 (4) 833-835; DOI: https://doi.org/10.3122/jabfm.2022.04.210539
Jonathan J. Darrow
From Program On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Department of Law & Taxation, Bentley University, Waltham, MA, USA; and McCallum Graduate School of Business, Bentley University, Waltham, MA, USA.
SJD, LLM, JD, MBAElizaveta Borisova
From Program On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Department of Law & Taxation, Bentley University, Waltham, MA, USA; and McCallum Graduate School of Business, Bentley University, Waltham, MA, USA.
BS, MS
References
- 1.↵
- Allahwala UK,
- Nadkarni A,
- Sebaratnam DF
- 2.↵Engaging patients through social media: is healthcare ready for empowered and digitally demanding patients? (2014). Available at https://fdocuments.in/document/social-media-in-healthcare-report-2014.html.
- 3.↵
- 4.↵
- de Haan S
- 5.↵FDA. Approved drug products with therapeutic equivalence evaluations (40th ed. 2020). Available at http://www.fdalawblog.net/wp-content/uploads/2020/06/OB-Annual-2020-40th-Ed.pdf.
- 6.↵
- Darrow JJ
- 7.↵
- Skancke KH,
- Svendsen K
- 8.↵
In this issue
Communication of Drug Efficacy Information via a Popular Online Platform
Jonathan J. Darrow, Elizaveta Borisova
The Journal of the American Board of Family
Medicine Jul 2022, 35 (4) 833-835; DOI: 10.3122/jabfm.2022.04.210539
Jump to section
Related Articles
- No related articles found.